Ograniczanie wyników

Czasopisma help

  1. 8 Journal of Physiology and Pharmacology

  2. 6 Archivum Immunologiae et Therapiae Experimentalis

  3. 2 Acta Biochimica Polonica

  4. 2 Weterynaria w Praktyce

  5. 1 BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology

Więcej...
Autorzy help

  1. 2 Brymora A.

  2. 2 Flisinski M.

  3. 2 Grywalska E.

  4. 2 Manitius J.

  5. 2 Mielnik M.

Więcej...
Lata help

  1. 5 2020

  2. 3 2019

  3. 3 2018

  4. 2 2017

  5. 2 2015

Więcej...
Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 23

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 2 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  chronic kidney disease
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 2 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Elastase, alpha1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis

100%
Polanska B., Augustyniak D., Makulska I., Niemczuk M., Jankowski A., Zwolinska D.
Archivum Immunologiae et Therapiae Experimentalis
|
2014
|
tom 62
|
nr 3
2

CTLA‑4 expression inversely correlates with kidney function and serum immunoglobulin concentration in patients with primary glomerulonephritides

100%
Grywalska E., Smarz-Widelska I., Mertowski S., Gosik K., Mielnik M., Podgajna M., Abramiuk M., Drop B., Rolinski J., Zaluska W.
Archivum Immunologiae et Therapiae Experimentalis
|
2019
|
tom 67
|
nr 5
3

Oxidative stress in kidney diseases: the cause or the consequence?

100%
Krata N., Zagozdzon R., Foroncewicz B., Mucha K.
Archivum Immunologiae et Therapiae Experimentalis
|
2018
|
tom 66
|
nr 3
4

Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease

100%
Hayasi K., Itoh H.
Archivum Immunologiae et Therapiae Experimentalis
|
2015
|
tom 63
|
nr 3
5
Content available remote

Expression of purinergic P2X7 receptors in subpopulations of peripheral blood mononuclear cells in early-stage of chronic kidney disease

84%
Lajdova I., Oksa A., Horvathova M., Spustova V.
Journal of Physiology and Pharmacology
|
2017
|
tom 68
|
nr 5
6
Content available remote

The activation of complement system in different types of renal replacement therapy

84%
Stepniewska J., Dolegowska B., Golebiewska E., Marchelek-Mysliwiec M., Domanski M., Ciechanowski K., Zair L.
Journal of Physiology and Pharmacology
|
2020
|
tom 71
|
nr 2
7
Content available remote

Chronic kidney disease leads to hypoxia inducible factor-1alpha to hypoxia inducible factor-2alpha switch in the gastrocnemius muscle

84%
Flisinski M., Wisniewska-Chudy E., Brymora A., Stefanska A., Strozecki P., Manitius J.
Journal of Physiology and Pharmacology
|
2017
|
tom 68
|
nr 3
8

Ficolin-2 gene rs7851696 polymorphism is associated with delayed graft function and acute rejection in kidney allograft recipients

84%
Dabrowska-Zamojcin E., Czerewaty M., Malinowski D., Tarnowski M., Sluczanowska-Glabowska S., Domanski L., Safranow K., Pawlik A.
Archivum Immunologiae et Therapiae Experimentalis
|
2018
|
tom 66
|
nr 1
9

OPG-RANK-RANKL signaling system and its significance in nephrology

84%
Klejna K., Naumnik B., Gasowska K., Mysliwiec M.
Folia Histochemica et Cytobiologica
|
2009
|
tom 47
|
nr 2
199-206
10
Content available remote

Morphometric analysis of muscle fibre types in rat locomotor and postural skeletal muscles in different stages of chronic kidney disease

84%
Flisinski M., Brymora A., Elminowska-Wenda G., Bogucka J., Walasik K., Stefanska A., Strozecki P., Manitius J.
Journal of Physiology and Pharmacology
|
2014
|
tom 65
|
nr 4
11

Vitamin K status in peritoneally dialyzed patients with chronic kidney disease

84%
Stankowiak-Kulpa H., Krzyzanowska P., Koziol L., Grzymislawski M., Wanic-Kossowska M., Moczko J., Walkowiak J.
Acta Biochimica Polonica
|
2011
|
tom 58
|
nr 4
Abnormal vitamin K status was documented in patients with chronic kidney diseases (CKD), especially those undergoing hemodialysis. The data related to patients undergoing peritoneal dialysis (PD) are contradictory. Therefore, in the present study we aimed to evaluate vitamin K status in patients with CKD who are treated with continuous ambulatory PD. Twenty-eight patients entered into the study. Dialysis vintage ranged from 3 to 89 months. Vitamin K status was assessed in all subjects using undercarboxylated prothrombin measurement (PIVKA-II). In addition, total protein and albumin levels, total cholesterol, LDL cholesterol, triglyceride, calcium, urea and creatinine concentrations were determined. PIVKA-II concentrations were abnormal in 13 (46.4 %) subjects. BMI values, both total and LDL cholesterol concentrations were significantly higher in patients with than those without vitamin K deficiency. Moreover, PIVKA II levels correlated with BMI values (r = 0.441, p < 0.019), LDL cholesterol (r = 0.434, p < 0.021) and creatinine (r = 0.406, p < 0.032) concentrations. However, through the use of logistic regression analysis and multiple regression analysis, no clinical factor was documented to be the independent risk factor of vitamin K deficiency. In conclusion, vitamin K deficiency is a frequent condition in peritoneally dialyzed patients. Assessment of vitamin K status should become a standard procedure in this group of patients.
12

Early detection of active glomerular lesions in dogs and cats using podocin

84%
Szczepankiewicz B., Paslawska U., Nowak M., Bachor R., Czyzewska-Buczynska A., Paslawski R., Szewczuk Z.
Journal of Veterinary Research
|
2019
|
tom 63
|
nr 4
13

Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase

84%
Zachara B. A., Gromadzinska J., Zbrog Z., Swiech R., Wasowicz W., Twardowska E., Jablonska E., Sobala W.
Acta Biochimica Polonica
|
2009
|
tom 56
|
nr 1
183-187
Background: Numerous authors have shown that selenium (Se) concentration and glutathione peroxidase (GSH-Px) activity in plasma of chronic kidney disease (CKD) patients are lower than in healthy subjects, but there are only few publications on the level of GSH-Px protein in those patients and no reports on the effect of Se supplementation to HD patients on the level of this enzyme. Subjects and Methods: Se concentration and GSH-Px protein level in plasma were measured in a group of 30 CKD patients on hemodialysis (HD) supplemented with 200 μg Se/day for 3 months, and 28 patients on HD administered with placebo. Se concentration was measured by graphite furnace atomic absorption spectrometry and plasma GSH-Px protein level by the sandwich ELISA method using polyclonal antibody specific for human plasma GSH-Px. Results: Se concentration in patients on placebo did not change throughout the 3-month study period, but increased significantly in Se supplemented group. Se supplementation to CKD patients on HD had no effect on the level of GSH-Px protein. Conclusions: The lack of GSH-Px protein in CKD patients on HD is not linked to Se deficiency since the level of this element increased after Se supplementation while enzyme protein level did not change. The damaged kidney of HD patients is unable to synthesize GSH-Px, even after induction with selenium.
14
Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik
Content available

Neopterin in patients with chronic kidney disease and patients with coronary artery disease

84%
Formanowicz D.
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology
|
2012
|
tom 93
|
nr 1
15
Content available remote

Potential association between elevated serum human epididymis protein 4 and chronic kidney disease in female patient

84%
Meng Z.-J., Li X.-J., Liu F., Li R.-S., Liang H.-P.
Journal of Physiology and Pharmacology
|
2020
|
tom 71
|
nr 6
16
Content available remote

The urine podocin/creatinine ratio as a novel biomarker of cardiorenal syndrome in dogs due to degenerative mitral valve disease

84%
Szczepankiewicz B., Paslawska U., Paslawski R., Gebarowski T., Zasada W., Michalek M., Noszczyk-Nowak A.
Journal of Physiology and Pharmacology
|
2019
|
tom 70
|
nr 2
17
Content available remote

Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study

84%
Mrozikiewicz-Rakowska B., Maroszek P., Nehring P., Sobczyk-Kopciol A., Krzyzewska M., Kaszuba A. M., Lukawska M., Chojnowska N., Kozka M., Bujalska-Zadrozny M., Ploski R., Krzymien J., Czupryniak L.
Journal of Physiology and Pharmacology
|
2015
|
tom 66
|
nr 5
18
Content available remote

Lipoxin (LTX A4 5S, 6R, 15R) levels drastically decrease after 5 years of hemodialysis treatment

67%
Szczuko M., Palma J., Drozd A., Stachowska E., Marlicz W., Malgorzewicz S., Debska-Slizien A., Rutkowski P., Kaczkan M.
Journal of Physiology and Pharmacology
|
2020
|
tom 71
|
nr 3
19
Content available remote

Comparison of a statin vs. hypolipemic diet on the oxidant status in hemodialyzed patients with chronic renal failure

67%
Mastalerz-Migas A., Reksa D., Pokorski M., Steciwko A., Muszynska A., Bunio A., Drobnik J., Pokorna-Kalwak D.
Journal of Physiology and Pharmacology. Supplement
|
2007
|
tom 58
|
nr 5
20

The PD-1/PD-L1 inhibitory pathway is altered in primary glomerulonephritides

67%
Grywalska E., Smarz-Widelska I., Krasowska-Zajac E., Korona-Glowniak I., Zaluska-Patel K., Mielnik M., Podgajna M., Malm A., Rolinski J., Zaluska W.
Archivum Immunologiae et Therapiae Experimentalis
|
2018
|
tom 66
|
nr 2
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 2 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.